Potassium Chloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Potassium Chloride
- Generic name
- POTASSIUM CHLORIDE
- Manufacturer
- IPG Pharmaceuticals, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 5dad0879-0f97-4c7d-98fa-baaed51cd2d8
- SPL ID
- 0f19da2c-a9ab-44fe-a38b-acb56c1c1883
- Version
- 2
- Effective date
- 2026-10-01
- Source export date
- 2026-11-13
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-13/829e43b83940afb8dda22d5287c5b17e57d3fe45d1157678854b4f9b7ad07271/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
- Import run
- 20261116T150851Z
- Imported at
- 2026-11-16 17:15:27
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 208019 | derived:openfda.application_number |
| application number | NDA208019 | openfda.application_number | |
| brand name | Potassium Chloride | openfda.brand_name | |
| generic name | POTASSIUM CHLORIDE | openfda.generic_name | |
| manufacturer name | IPG Pharmaceuticals, Inc. | openfda.manufacturer_name | |
| ndc | package | 71085-083-01 | openfda.package_ndc |
| ndc | package | 71085-083-30 | openfda.package_ndc |
| ndc | product | 71085-083 | openfda.product_ndc |
| ndc11 | package | 71085008330 | derived:openfda.package_ndc |
| ndc11 | package | 71085008301 | derived:openfda.package_ndc |
| rxcui | 2728724 | openfda.rxcui | |
| spl id | 0f19da2c-a9ab-44fe-a38b-acb56c1c1883 | id | |
| spl set id | 5dad0879-0f97-4c7d-98fa-baaed51cd2d8 | set_id | |
| unii | 660YQ98I10 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact IPG Pharmaceuticals, Inc. at 1-888-711-7116 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.